KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to -$44.9 million.

  • Idexx Laboratories' Cash from Investing Activities fell 6395.43% to -$44.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$148.0 million, marking a year-over-year increase of 2514.6%. This contributed to the annual value of -$207.1 million for FY2024, which is 6531.37% down from last year.
  • As of Q3 2025, Idexx Laboratories' Cash from Investing Activities stood at -$44.9 million, which was down 6395.43% from -$33.6 million recorded in Q2 2025.
  • Idexx Laboratories' 5-year Cash from Investing Activities high stood at -$24.6 million for Q1 2021, and its period low was -$174.7 million during Q2 2021.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$39.8 million (2024), whereas its average is -$48.9 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first tumbled by 61128.44% in 2021, then surged by 7231.26% in 2025.
  • Over the past 5 years, Idexx Laboratories' Cash from Investing Activities (Quarter) stood at -$44.0 million in 2021, then decreased by 11.78% to -$49.2 million in 2022, then surged by 38.18% to -$30.4 million in 2023, then tumbled by 30.91% to -$39.8 million in 2024, then fell by 12.62% to -$44.9 million in 2025.
  • Its last three reported values are -$44.9 million in Q3 2025, -$33.6 million for Q2 2025, and -$29.6 million during Q1 2025.